Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin for chronic low back pain with Modic type I changes
NL-OMON61000Phase 4Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Low back pain (LBP) comparing Amoxicillin with Placebo (2 arms). Primary endpoint: Roland Morris Disability Questionnaire score. Started Dec 2024; status: active, not recruiting.
02
Drugs
amoxicillin
03
Conditions
Low back pain (LBP)
Beyond the preview
Go deeper on NL-OMON61000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON61000.